Infants with a rare and fatal congenital disorder called Wolman disease in England and Wales will soon have access to a new drug via the NHS that can dramatically extend their lives. The National ...

Schorr and Wolman 1,2 and further reports have appeared 3,4. Failure to thrive, severe malabsorption and hepatosplenomegaly are early manifestations of the disease. Histochemical examination of ...

Isabella Cueto covers the leading causes of death and disability: chronic diseases. Her focus includes autoimmune conditions and diseases of the lungs, kidneys, liver (and more). She writes about ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted rare pediatric disease designation for OCU410ST, a gene therapy designed to treat ABCA4 ...

ALS stands for amyotrophic lateral sclerosis and is also known as Lou Gehrig's disease. Stephen Hawking lived with ALS for 55 years and advocated for research and helped bring awareness to the disease ...

LAS VEGAS (KTNV) — The Southern Nevada Health District advises guests who have recently stayed at The Grandview or South Point Hotel to monitor symptoms of Legionnaires’ disease and take ...

The Antibiotic That Takes the Bite out of Lyme Apr. 23, 2025 — Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the ...

While rare genetic diseases are uncommon, as their name suggests, there are more than 7,000 types of disease caused by mutations in more than 5,000 known genes, affecting approximately 300 million ...

Joyce Siette receives funding from the National Health and Medical Research Council on a Targeted Call for Research on cultural, ethnic and linguistic diversity in dementia research. A new study ...

With Lyme disease in Michigan surging as much as 168% in the last five years, health officials are warning residents to take steps to protect themselves during the Memorial Day weekend.

"In IPF, the drug reduced disease progression by more than 50% over the 52-week trial duration (the trial randomized 1,177 patients, treated with nerandomilast 9 or 18 mg daily or placebo); and in ...